DESTINY ROBERTSON: Open Payments
NPI 1629645015 · GOLDSBY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 63 payments from 16 companies in 2025. Trend: 2023 $1,693 · 2024 $1,078 · 2025 $1,297
Food & beverage: $1,297
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $335 |
| Novo Nordisk Inc | 12 | $185 |
| PFIZER INC. | 8 | $157 |
| Lilly USA, LLC | 6 | $129 |
| Astellas Pharma US Inc | 5 | $112 |
| ABBVIE INC. | 4 | $85 |
| Corcept Therapeutics | 3 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| GlaxoSmithKline, LLC. | 2 | $28 |
Products named: AIRSUPRA, Veozah, NURTEC ODT, Ozempic, FARXIGA, MOUNJARO, Korlym, UBRELVY.
Industry payments across OK — which companies pay providers there.
